Boston Scientific Stock: Is Wall Street Bullish or Bearish?

Marlborough, Massachusetts-based Boston Scientific Corporation (BSX) develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company has a market cap of $86.9 billion and operates through the MedSurg and Cardiovascular segments.

Shares of the company have lagged behind the broader market over the past year and in 2026. BSX stock has declined 44.4% over the past 52 weeks and 40.1% on a YTD basis. In comparison, the S&P 500 Index ($SPX) has returned 28.3% over the past year and risen 4.2% in 2026.